Table 5.
Incidences of Brevundimonas spp. Pseudo-infection from 1978 – 2017. Main characteristics of the case reports.
| Author (Ref) | Year | Sex/Age | Country | Co-morbidity | Type of infection | Susceptible to | Resistance to | Antibiotic treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| Kim et al. [50], B. diminuta | 2011 | Multiple (3 cases) | South Korea | Multiple | Pseudobacteraemia | N/A | Amikacin, Ciprofloxacin, Colistin, Ceftazidime, Cefepime, Cefotaxime Imipenem, Piperacillin / Tazobactam, Tobramycin | Ampicillin / sulbactam, Cefpiran, Metronidazole, Netilmicin | N/A |
| Lee et al. [51], B. diminuta | 2017 | Multiple (12 cases) | USA | Multiple | Pesudo-infection | Levofloxain, Meropenem, Piperacillin/tazobactam, Trimethoprim–sulfamethoxazole | Ceftazidime | N/A | N/A |
M- Male, F- Female, N/A – Not Available